Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

64 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Survival is better predicted with a new classification of stage III unresectable non-small cell lung carcinoma treated by chemotherapy and radiotherapy.
Berghmans T, Lafitte JJ, Thiriaux J, VanHoutte P, Lecomte J, Efremidis A, Koumakis G, Giner V, Richez M, Corhay JL, Wackenier P, Lothaire P, Mommen P, Ninane V, Sculier JP; European Lung Cancer Working Party. Berghmans T, et al. Among authors: thiriaux j. Lung Cancer. 2004 Sep;45(3):339-48. doi: 10.1016/j.lungcan.2004.02.016. Lung Cancer. 2004. PMID: 15301874
A four-drug combination chemotherapy with cisplatin, mitomycin, vindesine and 5 fluorouracile: a regimen associated with major toxicity in patients with advanced non-small cell lung cancer.
Klastersky J, Sculier JP, Ries F, Dabouis G, Libert P, Schmerber J, Thiriaux J, Berchier MC, Bureau G, Van Cutsem O, et al. Klastersky J, et al. Among authors: thiriaux j. Lung Cancer. 1994 Dec;11(5-6):373-84. doi: 10.1016/0169-5002(94)92166-0. Lung Cancer. 1994. PMID: 7704494 Clinical Trial.
Phase II randomized trial comparing high-dose cisplatin with moderate-dose cisplatin and carboplatin in patients with advanced non-small-cell lung cancer. European Lung Cancer Working Party.
Sculier JP, Klastersky J, Giner V, Bureau G, Thiriaux J, Dabouis G, Efremidis A, Ries F, Berchier MC, Sergysels R, et al. Sculier JP, et al. Among authors: thiriaux j. J Clin Oncol. 1994 Feb;12(2):353-9. doi: 10.1200/JCO.1994.12.2.353. J Clin Oncol. 1994. PMID: 8113843 Clinical Trial.
Phase III randomized trial comparing cisplatin and carboplatin with or without ifosfamide in patients with advanced non-small-cell lung cancer. European Lung Cancer Working Party.
Sculier JP, Paesmans M, Thiriaux J, Lecomte J, Bureau G, Giner V, Efremidis A, Lafitte JJ, Berchier MC, Alexopoulos CG, Zacharias C, Mommen P, Ninane V, Klastersky J. Sculier JP, et al. Among authors: thiriaux j. J Clin Oncol. 1998 Apr;16(4):1388-96. doi: 10.1200/JCO.1998.16.4.1388. J Clin Oncol. 1998. PMID: 9552042 Clinical Trial.
Response to chemotherapy has predictive value for further survival of patients with advanced non-small cell lung cancer: 10 years experience of the European Lung Cancer Working Party.
Paesmans M, Sculier JP, Libert P, Bureau G, Dabouis G, Thiriaux J, Michel J, Van Cutsem O, Sergysels R, Mommen P, Klastersky J. Paesmans M, et al. Among authors: thiriaux j. Eur J Cancer. 1997 Dec;33(14):2326-32. doi: 10.1016/s0959-8049(97)00325-0. Eur J Cancer. 1997. PMID: 9616276
Evaluation of the TN sub-staging in patients with initially unresectable stage III non-small cell lung cancer treated by induction chemotherapy. The European Lung Cancer Working Party.
Sculier JP, Paesmans M, Ninane V, Giner V, Bureau G, Lafitte JJ, Baumöhl J, Thiriaux J, van Cutsem O, Recloux P, Berchier MC, Zacharias C, Mommen P, van Houtte P, Klastersky J. Sculier JP, et al. Among authors: thiriaux j. Lung Cancer. 1998 Dec;22(3):201-13. doi: 10.1016/s0169-5002(98)00089-0. Lung Cancer. 1998. PMID: 10048473
A randomised phase III trial comparing consolidation treatment with further chemotherapy to chest irradiation in patients with initially unresectable locoregional non-small-cell lung cancer responding to induction chemotherapy. European Lung Cancer Working Party.
Sculier JP, Paesmans M, Lafitte JJ, Baumöhl J, Thiriaux J, van Cutsem O, Recloux P, Bureau G, Berchier MC, Zacharias C, Mommen P, Bosschaerts T, Berghmans T, van Houtte P, Ninane V, Klastersky J. Sculier JP, et al. Among authors: thiriaux j. Ann Oncol. 1999 Mar;10(3):295-303. doi: 10.1023/a:1008319506107. Ann Oncol. 1999. PMID: 10355573 Free article. Clinical Trial.
64 results